| Authors: |
De Ramón C; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain., Rojas EA; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain., Misiewicz-Krzeminska I; Department of Experimental Hematology Institute of Hematology and Transfusion Medicine Warsaw Poland., Cardona-Benavides IJ; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain., Cuadrado M; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain., Isidro I; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain., Calasanz MJ; Department of Hematology Clínica Universidad de Navarra, Centro de Investigaciones Biomédicas Aplicadas (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA) Pamplona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)., Fernandez M; Spanish National Cancer Research Center (CNIO) Madrid Spain.; Department of Hematology, University Hospital 12 de Octubre; Medicine Department Complutense University Madrid Madrid Spain., García-Sanz R; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)., Puig N; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain., Cedena MT; Spanish National Cancer Research Center (CNIO) Madrid Spain.; Department of Hematology, University Hospital 12 de Octubre; Medicine Department Complutense University Madrid Madrid Spain., Paiva B; Department of Hematology Clínica Universidad de Navarra, Centro de Investigaciones Biomédicas Aplicadas (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA) Pamplona Spain., Rosiñol L; Department of Hematology Hospital Clinic of Barcelona, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS) Barcelona Spain., Martínez-López J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC).; Spanish National Cancer Research Center (CNIO) Madrid Spain.; Department of Hematology, University Hospital 12 de Octubre; Medicine Department Complutense University Madrid Madrid Spain., Bladé J; Department of Hematology Hospital Clinic of Barcelona, Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS) Barcelona Spain., Lahuerta JJ; Department of Hematology University Hospital 12 de Octubre Madrid Spain., San Miguel JF; Department of Hematology Clínica Universidad de Navarra, Centro de Investigaciones Biomédicas Aplicadas (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA) Pamplona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)., Mateos MV; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)., Corchete LA; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)., Gutiérrez NC; Department of Hematology, University Hospital of Salamanca Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Cancer Research Center-IBMCC (USAL-CSIC) Salamanca Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC). |
